Entrepreneur Seamus Mulligan Cashes In $86 Million Of Jazz Pharmaceuticals plc (JAZZ) To Fund New Venture
3/21/2014 8:19:52 AM
Entrepreneur Séamus Mulligan has cashed in shares worth $86 million (€62 million) in Jazz Pharmaceuticals which will entirely be used to fund a new business called Adapt Pharma. Mr Mulligan has co-founded Dublin-based Adapt with fellow serial pharmaceutical entrepreneurs David Brabazon and Eunan Maguire. All three men previously worked with Elan Pharmaceuticals before they successfully co-founded a company called Azur Pharma, which merged with Jazz Pharmaceuticals in 2012.
Help employers find you! Check out all the jobs and post your resume.
comments powered by